
Episode #14
New Therapies for MASH: What Healthcare Teams Need to Know
A common liver disease is quietly affecting millions of Americans. Are we doing enough to catch it early? In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Sara Klockars, PharmD, explores the growing prevalence of MASLD and MASH. She reviews newly approved treatment options, including semaglutide and resmetirom, and discusses how healthcare teams can help identify, support, and manage patients throughout their care journey. This is an excerpt from our April 2026 Pharmacy Essential Updates continuing education webinar series. ️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights : Article: Know the Latest MASH Treatment Options Chart: Comparison of Drugs for Metabolic Liver Disease Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Are you a student? Great news—students can access a free version of Pharmacist’s Letter . Send us Fan Mail Email us: ContactUs@trchealthcare.com . The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here . Learn more about our product offerings at trchealthcare.com .

